|
Suppliers for CAS
1051375-10-0
(3S,11aR)-N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
|
Properties | | CAS |
1051375-10-0 | | Formula |
C19H17F2N3O5 |
|
7 Registered suppliers
Amadis Chemical Company Limited
P.R.China
(3S,11aR)-N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
Dayang Chem (Hangzhou) Co.,Ltd.
P.R.China
(3S,11aR)-N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd)
P.R.China
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C19H17F2N3O5
Molecular Weight: 405.3521864
Aea.ltd
P.R.China
Molecular Formula: C19H17F2N3O5
Molecular Weight: 405.3521864
Molecular Formula: C19H17F2N3O5
Molecular Weight: 405.3521864
Molecular Formula: C19H17F2N3O5
Molecular Weight: 405.3521864
BOC Sciences
USA
Description : Cabotegravir (GSK744, GSK1265744) is a long-acting HIV integrase inhibitor against a broad range of HIV subtypes, and inhibits the HIV-1 integrase catalyzed strand transfer reaction with IC50 of 3.0 nM. Phase 2. - Molecular Weight :405.35
- Boiling Point :664.0±55.0 °C at 760 mmHg
- Purity :> 98%
Molecular Formula : C19H17F2N3O5 Canonical SMILES : CC1COC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O
InChI :
InChI=1S/C19H17F2N3O5/c1-9-8-29-14-7-23-6-12(16(25)17(26)15(23)19(28)24(9)14)18(27)22-5-10-2-3-11(20)4-13(10)21/h2-4,6,9,14,26H,5,7-8H2,1H3,(H,22,27)/t9-,14+/m0/s1
InChIKey :
WCWSTNLSLKSJPK-LKFCYVNXSA-N
Solubility :
In Vitro: DMSO : 16.67 mg/mL(41.12 mM;Need ultrasonic) In Vivo: 1.Add each solvent one by one:10% DMSO > > 90%corn oil Solubility: ≥ 1.67 mg/mL (4.12 mM); Clear solution
Appearance :
White to off-white (Solid)
Application :
HIV Integrase Inhibitors
Storage : Store at -20°C
Synonyms :
S/GSK1265744; S/GSK 1265744; S/GSK-1265744; GSK744; GSK-744; GSK 744; Cabotegravir.
More details are to be found here
Allfluoro Pharmaceutical Co. Ltd.
P.R.China
MDL: MFCD25976748
MF: C19H17F2N3O5
MW: 405,35
|
_Co_Ltd_1_575.jpg){kind=logo}
details
details